Smith & Nephew plc Share Price & Technical Analysis

SNN · $30.53 (-0.75%)

Healthcare / Medical Devices

AI Score 32 · Bearish

$30.53

-0.75%

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom, the United States, and internationally. The company operates in three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. It offers knee implant products for knee replacement procedures; hip implants for revision procedures; tr

Price chart

Seasonality

May has 2 positive and 2 negative years (last 5 years shown)

-2% return in May, -1% avg return in past 3 year May month.

-3% return in 2026, 12% avg return in past 3 years.

Swipe sideways to see all months →

JanFebMarAprMayJunJulAugSepOctNovDecYr
264%8%-10%-3%-2%-3%
252%15%-4%-1%2%6%1%23%-1%1%-9%0%34%
244%-5%-4%-3%1%0%16%2%2%-19%1%-4%-11%
233%3%-4%17%-8%8%0%-11%-8%-9%16%5%12%
22-2%4%-10%1%0%-15%-6%-6%-2%1%10%1%-23%

Monthly return % by calendar month · historical pattern, not a forecast

AI snapshotScore 32/100

Bearish · Downtrend · Neutral

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom, the United States, and internationally. The company operates in three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. It offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products. The company also provides sports medicine joint repair products comprise instruments, technologies, and implants to perform minimally invasive surgery, as well as treating soft tissue injuries and degenerative conditions of the shoulder, knee, hip, and small joints. In addition, it provides arthroscopic enabling technologies comprising fluid management equipment for surgical access, cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions. Further, the company offers advanced wound care products for the treatment and prevention of acute and chronic wounds, leg, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, such as biologics and other bioactive technologies for debridement and dermal repair/regeneration, and regenerative medicine products, including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems. It serves the healthcare providers. Smith & Nephew plc was founded in 1856 and is headquartered in Watford, the United Kingdom.

Full AI Q&A, portfolio tracking, and live alerts in the app.

Key metrics

Market cap

$12.75B

P/E ratio

20.88

52W high

$38.79

52W low

$28.40

Volume

10,00,759

Beta

0.67

Related stocks in Healthcare

Frequently asked questions

What is Smith & Nephew plc share price today?
Smith & Nephew plc (SNN) last traded around $30.53 on StockPro. Prices refresh every few minutes during market hours.
What technical signals does SNN have?
StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for SNN. Download the app for real-time alerts.
How can I analyze Smith & Nephew plc stock?
Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.

Explore more on StockPro